Lung-RADS | Category descriptor | Findings | Management |
0 | Incomplete Estimated population prevalence: ~1% | Prior chest CT examination being located for comparison (see note 9) | Comparison to prior chest CT |
Part or all of lungs cannot be evaluated | Additional lung cancer screening CT imaging needed | ||
Findings suggestive of an inflammatory or infectious process (see note 10) | 1 to 3 month LDCT | ||
1 | Negative Estimated population prevalence: 39% | No lung nodules OR | 12-month screening LDCT |
Nodule with benign features:
| |||
2 | Benign Based on imaging features or indolent behavior Estimated population prevalence: 45% | Juxtapleural nodule:
| |
Solid nodule:
| |||
Part-solid nodule:
| |||
Non-solid nodule (GGN):
| |||
Airway nodule, subsegmental at baseline, new, or stable (see note 11) | |||
Category 3 nodule that is stable or decreased in size at 6-month follow-up CT, OR Category 3 or 4A nodules that resolve on follow-up, OR Category 4B findings proven to be benign in etiology following appropriate diagnostic workup | |||
3 | Probably benign Based on imaging features or behavior Estimated population prevalence: 9% | Solid nodule:
| 6-month LDCT |
Part-solid nodule:
| |||
Non-solid nodule (GGN):
| |||
Atypical pulmonary cyst: (see note 12)
| |||
Category 4A nodule that is stable or decreased in size at 3-month follow-up CT (excluding airway nodules) | |||
4A | Suspicious Estimated population prevalence: 4% | Solid nodule:
| 3-month LDCT; PET/CT may be considered if there is a ≥8 mm (≥268 mm3) solid nodule or solid component |
Part-solid nodule:
| |||
Airway nodule, segmental or more proximal at baseline or new (see note 11) | |||
Atypical pulmonary cyst: (see note 12)
| |||
4B | Very suspicious Estimated population prevalence: 2% | Airway nodule, segmental or more proximal, and stable or growing (see note 11) | Referral for further clinical evaluation |
Solid nodule:
| Diagnostic chest CT with or without contrast; PET/CT may be considered if there is a ≥8 mm (≥268 mm3) solid nodule or solid component; tissue sampling; and/or referral for further clinical evaluation Management depends on clinical evaluation, patient preference, and the probability of malignancy (see note 13) | ||
Part-solid nodule:
| |||
Atypical pulmonary cyst: (see note 12)
| |||
Slow-growing-solid or part-solid nodule that demonstrates growth over multiple screening exams (see note 8) | |||
4X | Estimated population prevalence: <1% | Category 3 or 4 nodules with additional features or imaging findings that increase suspicion for lung cancer (see note 14) | |
S | Significant or potentially significant Estimated population prevalence: 10% | Modifier: May add to category 0 to 4 for clinically significant or potentially clinically significant findings unrelated to lung cancer (see note 15) | As appropriate to the specific finding |
آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟